文献速递甲状腺与浅表技术与安全US

2012至2015年美国一家四级医疗中心住院与急诊成人甲状腺超声的净收入分析

Net Revenue Analysis of Inpatient and Emergency Department Thyroid Ultrasound at a US Quaternary Care Center From 2012 to 2015.
PubMed 文献 · J Am Coll Radiol · 2017-10-20

该研究回顾性分析2012年2月至2015年12月共10334例甲状腺超声检查的财务数据,其中门诊占97.4%、住院占2.1%、急诊占0.5%。住院与急诊每工时成本为15.30美元,高于门诊的7.65美元;住院及经急诊入院患者的技术补偿损失为44376美元,部分由急诊离院患者补偿9309美元。结论认为住院与急诊非急诊成人甲状腺超声的净收入损失和检查量均较低。

要点

  • 住院与急诊甲状腺超声每工时成本15.30美元,高于门诊的7.65美元。
  • 住院及经急诊入院患者技术补偿损失44376美元,急诊离院患者补偿9309美元。
  • 门诊专业补偿最高(均值37.39美元),且随付款方不同而变化。

核心结论

  • 住院与急诊非急诊成人甲状腺超声的净收入损失和影像检查量均较低。

研究设计与样本

  • 符合HIPAA、经机构审查委员会豁免的回顾性研究,纳入2012年2月至2015年12月共10334例甲状腺超声检查,比较149个付款方、多个时间段及就诊场所(门诊、急诊、住院)的专业与技术补偿和利用趋势。

诊断标准与关键数值

  • 门诊甲状腺超声占97.4%(10069/10334),住院占2.1%(217/10334),急诊占0.5%(48/10334)。
  • 住院与急诊每工时成本为15.30美元,门诊为7.65美元。
  • 门诊专业补偿最高(均值37.39美元),随付款方不同而变化(专有数据;每检查标准差21.36美元)。
  • 住院及经急诊入院患者因诊断相关组计费导致的技术补偿损失为44376美元,由急诊离院患者的技术补偿部分补偿9309美元(每月平均技术补偿损失746美元)。
  • 利用率逐年增加并与Medicare业务量相关;住院利用率在Medicare患者中最高,门诊和急诊利用率在私人付款方患者中最高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to understand the financial ramifications of performing nonemergent inpatient and emergency department (ED) adult thyroid ultrasound studies at a US quaternary care center.

METHODS: A HIPAA-compliant, institutional review board-exempt retrospective review of 10,334 thyroid ultrasound studies performed between February 2012 and December 2015 was conducted. Demographic, imaging, clinical, and financial data were reviewed. Labor cost analysis was calculated using national salary data and local scheduling practices. Professional and technical reimbursement and utilization trends were compared across 149 payers, multiple time spans, and visit settings (outpatient, ED, and inpatient).

RESULTS: Most thyroid ultrasound studies were performed on outpatients (97.4% [10,069 of 10,334]), with a minority performed on inpatients (2.1% [217 of 10,334]) or in the ED (0.5% [48 of 10,334]). Man-hour cost of performing thyroid ultrasound was higher in the inpatient and ED settings ($15.30) compared with the outpatient setting ($7.65). Professional reimbursement was highest in the outpatient setting (mean, $37.39) and varied by payer (proprietary data; SD, $21.36 per examination). Technical reimbursement loss due to diagnosis-related group billing for inpatients and admitted-via-ED patients was $44,376; this was partly compensated ($9,309) by technical reimbursement from discharged-from-ED patients (mean technical reimbursement loss, $746 per month). Utilization increased year by year and correlated with Medicare volumes. Inpatient utilization was highest in Medicare patients; outpatient and ED utilization was highest for patients with private payers.

CONCLUSIONS: Net revenue loss from and imaging volumes of inpatient and ED nonemergent adult thyroid ultrasound studies are low.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Parikh K, Davenport MS. Net Revenue Analysis of Inpatient and Emergency Department Thyroid Ultrasound at a US Quaternary Care Center From 2012 to 2015. J Am Coll Radiol. 2017. PMID: 29066070. doi:10.1016/j.jacr.2017.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。